Analysis of ifosforamide mustard, the active metabolite of ifosfamide, in plasma

Journal of Chromatography B: Biomedical Applications

Volumn 686, Issue 2, 1996, Pages 249-255

  Kaijser, G P ^a   Beijnen, J H ^b   Rozendom, E ^c   Bult, A ^c   Underberg, W J M ^c  

^a CERM Centre Europeen de Recherches Mauvernay   (France)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Ifosfamide; Ifosforamide mustard

Indexed keywords

DRUG METABOLITE; IFOSFAMIDE;

ADULT; ARTICLE; CALIBRATION; DERIVATIZATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG METABOLISM; DRUG STABILITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SOLID PHASE EXTRACTION; TECHNIQUE; ULTRAVIOLET SPECTROPHOTOMETRY;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; IFOSFAMIDE; PHOSPHORAMIDE MUSTARDS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0030588972     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(96)00218-6     Document Type: Article

References (20)

1. [1] N. Brock, P. Hilgard, M. Peukert, J. Pohl and H. Sindermann, Cancer Invest., 6 (1988) 513.
2. [2] J.R. Mehta, M. Przybylski and D.B. Ludlum, Cancer Res., 40 (1980) 4183.
3. [3] I. Jardine, C. Fenselau, M. Appler, M.N. Kan, R.B. Brundrett and M. Colvin, Cancer Res., 38 (1978) 408.
4. [4] R.W. Hardy, M.J. Moore, C. Erlichman and S.J. Soldin, Ther. Drug Monit., 9 (1987) 221.
5. [5] F.D. Juma, H.J. Rogers and J.R. Trounce, Br. J. Clin. Pharmacol., 10 (1980) 327.
6. [6] B.M. Bryant, M. Jarman, M.H. Baker, I.E. Smith and J.F. Smyth, Cancer Res., 40 (1980) 4734.
7. [7] J.F. Powers and N.E. Sladek, Cancer Res., 43 (1983) 1101.
8. [8] R.F. Struck, M.C. Kirk, H. Maxie, M.H. Wit and W.R. Laster Jr., Biomed. Mass Spectrom., 2 (1975) 46.
9. [9] M.J. Lind, H.L. Roberts, N. Thatcher and J.R. Idle, Cancer Chemother. Pharmacol., 26 (1990) 105.
10. [10] A.V. Boddy and J.R. Idle, J. Chromatogr., 575 (1992) 137.
11. [11] N.E. Sladek, D. Doeden, J.F. Powers and W. Krivit, Cancer Treat. Rep., 68 (1984) 1247.
12. [12] J.J.H. Wang and K.K. Chan, J. Chromatogr. B, 674 (1995) 205.
13. [13] S. Genka, J. Deutsch, P.L. Stahle, H. Shetyy, V. John, C. Robinson, S.I. Rapoport and N.H. Greig, Cancer Chemother. Pharmacol., 27 (1990) 1.
14. [14] M. Colvin, R. Brundrett, N.K. Man-Ka, I. Jardine and C. Fenselau, Cancer Res., 36 (1976) 1121.
15. [15] N.E. Sladek, Cancer Res., 33 (1973) 651.
16. [16] E. Watson, D. Phoebe and K. Chan, J. Pharm. Sci., 74 (1985) 1283.
17. [17] T.W. Engle, G. Zon and W. Egan, J. Med. Chem., 25 (1982) 1347.
18. [18] J. Cummings, A. MacLellan and J.F. Smyth, Anal. Chem., 63 (1991) 1514.
19. [19] D. Munger, L.A. Sternson, A.J. Repta and T. Higuchi, J. Chromatogr., 143 (1977) 375.
20. [20] L.A. Sternson, J.F. Stobaugh, J. Reid and P. De Montigny, J. Pharm. Biomed. Anal., 6 (1988) 657.